W Burke, M Daly, J Garber, J Botkin, MJ Kahn, … - Jama, 1997 - Am Med Assoc OBJECTIVE: To provide recommendations for cancer surveillance and risk reduction
for individuals carrying mutations in the BRCA1 or BRCA2 genes. PARTICIPANTS: A
task force with expertise in medical genetics, oncology, primary care, ... Cited by 670 - Related articles - All 4 versions
AL Potosky, BA Miller, PC Albertsen, BS … - Jama, 1995 - Am Med Assoc OBJECTIVE--To assess the reasons for the dramatic surge in prostate cancer
incidence from 1986 to 1991. DESIGN--Population-based study of incidence rates
and procedures used to detect and diagnose prostate cancer derived from ... Cited by 429 - Related articles - BL Direct - All 4 versions
- ►oxfordjournals.org R Etzioni, DF Penson, JM Legler, D di … - JNCI Journal of the National Cancer Institute, 2002 - jnci.oxfordjournals.org Background: Overdiagnosis of clinically insignificant prostate cancer is
considered a major potential drawback of prostate-specific antigen (PSA)
screening. Quantitative estimates of the magnitude of this problem are, ... Cited by 376 - Related articles - BL Direct - All 10 versions
PC Albertsen, DG Fryback, BE Storer, TF Kolon … - Evidence-Based Medicine: A Framework for Clinical …, 1998 - books.google.com APPLICATION OF THE STUDY GUIDE/215 Reprinted from JAMA 9 The Journal of the
American Mcdital Association August 23/30. 1995 Volume 274 Copyright 1995,
American Medical Association Long-term Survival Among Men With ... Cited by 364 - Related articles - BL Direct - All 6 versions
- ►ascopubs.org F Kamangar, GM Dores, WF Anderson - Journal of Clinical Oncology, 2006 - jco.ascopubs.org In 2002, an estimated 11 million new cancer cases and 7 million cancer deaths
were reported worldwide; nearly 25 million persons were living with cancer.
Among the eight most common cancers, global disparities in cancer ... Cited by 353 - Related articles - All 7 versions
MD Krahn, JE Mahoney, MH Eckman, J … - Jama, 1994 - Am Med Assoc OBJECTIVE--To determine the clinical and economic effects of screening for
prostate cancer with prostate-specific antigen (PSA), transrectal ultrasound
(TRUS), and digital rectal examination (DRE). DESIGN--Decision analytic ... Cited by 312 - Related articles - BL Direct - All 4 versions
- ►jcojournal.org [PDF] JA Talcott, P Rieker, JA Clark, KJ Propert, … - Journal of Clinical Oncology, 1998 - jcojournal.org Purpose: To assess complications of therapy for early (nonmetastatic) prostate
cancer. Patients and Methods: A prospective study of a co- hort of 279 men who
sought treatment advice and completed required pretreatment forms. The ... Cited by 268 - Related articles - BL Direct - All 7 versions
PC Prorok, GL Andriole, RS Bresalier, SS … - Controlled clinical trials, 2000 - Elsevier The objectives of the Prostate, Lung, Colorectal and Ovarian Cancer Screening
Trial are to determine in screenees ages 55–74 at entry whether screening with
flexible sigmoidoscopy (60-cm sigmoidoscope) can reduce mortality from ... Cited by 265 - Related articles - BL Direct - All 3 versions
RA Smith, AC von Eschenbach, R Wender, B … - CA: A Cancer Journal for Clinicians, 2001 - Am Cancer Soc Updates to the American Cancer Society (ACS) guidelines regarding screening for
the early detection of prostate, colorectal, and endometrial cancers, based on
the recommendations of recent ACS workshops, are presented. Additionally, ... Cited by 237 - Related articles - BL Direct - All 4 versions
AB Flood, JE Wennberg, RF Nease, FJ Fowler … - Journal of general internal medicine, 1996 - Springer Received from the Center for the Evaluative Clinical Sciences, Department of
Community and Family Medicine, Dartmouth Medical School, Hanover, NH, where work
was performed (ABF, JEW, JD); Laboratory for Medical Decision Sciences, ... Cited by 230 - Related articles - BL Direct - All 4 versions
